Beal Anne 4

What Happened Anne Beal, a director of Omada Health, was granted 10,882 restricted stock units (RSUs) on June 16, 2026. The reported acquisition price is $0.00 (this is an equity award rather than a market purchase), so no cash changed hands in this transaction.

Key Details

• Transaction type: Award/Grant (Code A) — 10,882 RSUs granted on 2026-06-16.
• Reported price: $0.00 per share; reported aggregate cash value: $0.
• Filing date: 2026-06-18 (filed within the normal Form 4 reporting window).
• Vesting (Footnote F1): 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context RSUs are compensation awards that convert into common shares upon vesting; this grant does not represent an open-market purchase or sale and should be viewed as a compensation/retention event rather than a direct bullish or bearish trading signal.